 | • レポートコード：B-GIR08C4855 • 出版社/出版日：GlobalInfoResearch / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール • 産業分類：Medical Devices & Consumables |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、レア血液学の世界市場について調べ、まとめました。種類別セグメントは、組換え因子、血漿由来因子等、用途別セグメントは、等に区分しました。レア血液学の世界市場概観、企業動向、企業別レア血液学シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・レア血液学の市場概観 ・レア血液学の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・レア血液学の企業別販売動向、市場シェア、市場集中度、競争動向 ・レア血液学の世界市場規模 ・レア血液学の北米市場分析（アメリカ、カナダ、メキシコ等） ・レア血液学のアメリカ市場規模推移 ・レア血液学のカナダ市場規模推移 ・レア血液学のメキシコ市場規模推移 ・レア血液学のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・レア血液学のドイツ市場規模推移 ・レア血液学のイギリス市場規模推移 ・レア血液学のロシア市場規模推移 ・レア血液学のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・レア血液学の日本市場規模推移 ・レア血液学の中国市場規模推移 ・レア血液学の韓国市場規模推移 ・レア血液学のインド市場規模推移 ・レア血液学の東南アジア市場規模推移 ・レア血液学の南米市場分析（ブラジル、アルゼンチン等） ・レア血液学の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・レア血液学の種類別分析/販売量、売上、市場シェア（組換え因子、血漿由来因子） ・レア血液学の用途別分析/市場規模（） ・レア血液学の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・レア血液学の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Rare Hematology market is valued at million USD in 2018 and is expected to reach million USD by the end of 2024, growing at a CAGR of between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Rare Hematology.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Rare Hematology market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Rare Hematology market by product type and applications/end industries.
Market Segment by Companies, this report covers
Shire plc
Novo Nordisk A/S
Pfizer Inc.
Bayer Healthcare AG
CSL Behring LLC
Biogen Inc.
Alexion Pharmaceuticals, Inc.
Celgene Corporation
Amgen Inc.
PRA Health Sciences
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Recombinant Factors
Plasma Derived Factors
Market Segment by Applications, can be divided into
Pediatric
Adult
Table of Contents
1 Rare Hematology Market Overview
1.1 Product Overview and Scope of Rare Hematology
1.2 Classification of Rare Hematology by Types
1.2.1 Global Rare Hematology Revenue Comparison by Types (2019-2024)
1.2.2 Global Rare Hematology Revenue Market Share by Types in 2018
1.2.3 Recombinant Factors
1.2.4 Plasma Derived Factors
1.3 Global Rare Hematology Market by Application
1.3.1 Global Rare Hematology Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Pediatric
1.3.3 Adult
1.4 Global Rare Hematology Market by Regions
1.4.1 Global Rare Hematology Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Rare Hematology Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Rare Hematology Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Rare Hematology Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Rare Hematology Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Rare Hematology Status and Prospect (2014-2024)
1.5 Global Market Size of Rare Hematology (2014-2024)
2 Manufacturers Profiles
2.1 Shire plc
2.1.1 Business Overview
2.1.2 Rare Hematology Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Shire plc Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
2.2 Novo Nordisk A/S
2.2.1 Business Overview
2.2.2 Rare Hematology Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novo Nordisk A/S Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
2.3 Pfizer Inc.
2.3.1 Business Overview
2.3.2 Rare Hematology Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Inc. Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
2.4 Bayer Healthcare AG
2.4.1 Business Overview
2.4.2 Rare Hematology Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bayer Healthcare AG Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
2.5 CSL Behring LLC
2.5.1 Business Overview
2.5.2 Rare Hematology Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 CSL Behring LLC Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
2.6 Biogen Inc.
2.6.1 Business Overview
2.6.2 Rare Hematology Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Biogen Inc. Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
2.7 Alexion Pharmaceuticals, Inc.
2.7.1 Business Overview
2.7.2 Rare Hematology Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Alexion Pharmaceuticals, Inc. Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
2.8 Celgene Corporation
2.8.1 Business Overview
2.8.2 Rare Hematology Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Celgene Corporation Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
2.9 Amgen Inc.
2.9.1 Business Overview
2.9.2 Rare Hematology Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Amgen Inc. Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
2.10 PRA Health Sciences
2.10.1 Business Overview
2.10.2 Rare Hematology Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 PRA Health Sciences Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
3 Global Rare Hematology Market Competition, by Players
3.1 Global Rare Hematology Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Rare Hematology Players Market Share
3.2.2 Top 10 Rare Hematology Players Market Share
3.3 Market Competition Trend
4 Global Rare Hematology Market Size by Regions
4.1 Global Rare Hematology Revenue and Market Share by Regions
4.2 North America Rare Hematology Revenue and Growth Rate (2014-2019)
4.3 Europe Rare Hematology Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Rare Hematology Revenue and Growth Rate (2014-2019)
4.5 South America Rare Hematology Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Rare Hematology Revenue and Growth Rate (2014-2019)
5 North America Rare Hematology Revenue by Countries
5.1 North America Rare Hematology Revenue by Countries (2014-2019)
5.2 USA Rare Hematology Revenue and Growth Rate (2014-2019)
5.3 Canada Rare Hematology Revenue and Growth Rate (2014-2019)
5.4 Mexico Rare Hematology Revenue and Growth Rate (2014-2019)
6 Europe Rare Hematology Revenue by Countries
6.1 Europe Rare Hematology Revenue by Countries (2014-2019)
6.2 Germany Rare Hematology Revenue and Growth Rate (2014-2019)
6.3 UK Rare Hematology Revenue and Growth Rate (2014-2019)
6.4 France Rare Hematology Revenue and Growth Rate (2014-2019)
6.5 Russia Rare Hematology Revenue and Growth Rate (2014-2019)
6.6 Italy Rare Hematology Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Rare Hematology Revenue by Countries
7.1 Asia-Pacific Rare Hematology Revenue by Countries (2014-2019)
7.2 China Rare Hematology Revenue and Growth Rate (2014-2019)
7.3 Japan Rare Hematology Revenue and Growth Rate (2014-2019)
7.4 Korea Rare Hematology Revenue and Growth Rate (2014-2019)
7.5 India Rare Hematology Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Rare Hematology Revenue and Growth Rate (2014-2019)
8 South America Rare Hematology Revenue by Countries
8.1 South America Rare Hematology Revenue by Countries (2014-2019)
8.2 Brazil Rare Hematology Revenue and Growth Rate (2014-2019)
8.3 Argentina Rare Hematology Revenue and Growth Rate (2014-2019)
8.4 Colombia Rare Hematology Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Rare Hematology by Countries
9.1 Middle East and Africa Rare Hematology Revenue by Countries (2014-2019)
9.2 Saudi Arabia Rare Hematology Revenue and Growth Rate (2014-2019)
9.3 UAE Rare Hematology Revenue and Growth Rate (2014-2019)
9.4 Egypt Rare Hematology Revenue and Growth Rate (2014-2019)
9.5 Nigeria Rare Hematology Revenue and Growth Rate (2014-2019)
9.6 South Africa Rare Hematology Revenue and Growth Rate (2014-2019)
10 Global Rare Hematology Market Segment by Type
10.1 Global Rare Hematology Revenue and Market Share by Type (2014-2019)
10.2 Global Rare Hematology Market Forecast by Type (2019-2024)
10.3 Recombinant Factors Revenue Growth Rate (2014-2024)
10.4 Plasma Derived Factors Revenue Growth Rate (2014-2024)
11 Global Rare Hematology Market Segment by Application
11.1 Global Rare Hematology Revenue Market Share by Application (2014-2019)
11.2 Rare Hematology Market Forecast by Application (2019-2024)
11.3 Pediatric Revenue Growth (2014-2019)
11.4 Adult Revenue Growth (2014-2019)
12 Global Rare Hematology Market Size Forecast (2019-2024)
12.1 Global Rare Hematology Market Size Forecast (2019-2024)
12.2 Global Rare Hematology Market Forecast by Regions (2019-2024)
12.3 North America Rare Hematology Revenue Market Forecast (2019-2024)
12.4 Europe Rare Hematology Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Rare Hematology Revenue Market Forecast (2019-2024)
12.6 South America Rare Hematology Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Rare Hematology Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Rare Hematology Picture
Table Product Specifications of Rare Hematology
Table Global Rare Hematology and Revenue (Million USD) Market Split by Product Type
Figure Global Rare Hematology Revenue Market Share by Types in 2018
Figure Recombinant Factors Picture
Figure Plasma Derived Factors Picture
Table Global Rare Hematology Revenue (Million USD) by Application (2014-2024)
Figure Rare Hematology Revenue Market Share by Applications in 2018
Figure Pediatric Picture
Figure Adult Picture
Table Global Market Rare Hematology Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Rare Hematology Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Rare Hematology Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Rare Hematology Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Rare Hematology Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Rare Hematology Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Rare Hematology Revenue (Million USD) and Growth Rate (2014-2024)
Table Shire plc Basic Information, Manufacturing Base and Competitors
Table Shire plc Rare Hematology Type and Applications
Table Shire plc Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
Table Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk A/S Rare Hematology Type and Applications
Table Novo Nordisk A/S Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table Pfizer Inc. Rare Hematology Type and Applications
Table Pfizer Inc. Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Healthcare AG Basic Information, Manufacturing Base and Competitors
Table Bayer Healthcare AG Rare Hematology Type and Applications
Table Bayer Healthcare AG Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
Table CSL Behring LLC Basic Information, Manufacturing Base and Competitors
Table CSL Behring LLC Rare Hematology Type and Applications
Table CSL Behring LLC Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
Table Biogen Inc. Basic Information, Manufacturing Base and Competitors
Table Biogen Inc. Rare Hematology Type and Applications
Table Biogen Inc. Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
Table Alexion Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table Alexion Pharmaceuticals, Inc. Rare Hematology Type and Applications
Table Alexion Pharmaceuticals, Inc. Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
Table Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table Celgene Corporation Rare Hematology Type and Applications
Table Celgene Corporation Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Inc. Basic Information, Manufacturing Base and Competitors
Table Amgen Inc. Rare Hematology Type and Applications
Table Amgen Inc. Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
Table PRA Health Sciences Basic Information, Manufacturing Base and Competitors
Table PRA Health Sciences Rare Hematology Type and Applications
Table PRA Health Sciences Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
Table Global Rare Hematology Revenue (Million USD) by Players (2014-2019)
Table Global Rare Hematology Revenue Share by Players (2014-2019)
Figure Global Rare Hematology Revenue Share by Players in 2017
Figure Global Rare Hematology Revenue Share by Players in 2018
Figure Global Top 5 Players Rare Hematology Revenue Market Share in 2018
Figure Global Top 10 Players Rare Hematology Revenue Market Share in 2018
Figure Global Rare Hematology Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Rare Hematology Revenue (Million USD) by Regions (2014-2019)
Table Global Rare Hematology Revenue Market Share by Regions (2014-2019)
Figure Global Rare Hematology Revenue Market Share by Regions (2014-2019)
Figure Global Rare Hematology Revenue Market Share by Regions in 2018
Figure North America Rare Hematology Revenue and Growth Rate (2014-2019)
Figure Europe Rare Hematology Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Rare Hematology Revenue and Growth Rate (2014-2019)
Figure South America Rare Hematology Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Rare Hematology Revenue and Growth Rate (2014-2019)
Table North America Rare Hematology Revenue by Countries (2014-2019)
Table North America Rare Hematology Revenue Market Share by Countries (2014-2019)
Figure North America Rare Hematology Revenue Market Share by Countries (2014-2019)
Figure North America Rare Hematology Revenue Market Share by Countries in 2018
Figure USA Rare Hematology Revenue and Growth Rate (2014-2019)
Figure Canada Rare Hematology Revenue and Growth Rate (2014-2019)
Figure Mexico Rare Hematology Revenue and Growth Rate (2014-2019)
Table Europe Rare Hematology Revenue (Million USD) by Countries (2014-2019)
Figure Europe Rare Hematology Revenue Market Share by Countries (2014-2019)
Figure Europe Rare Hematology Revenue Market Share by Countries in 2018
Figure Germany Rare Hematology Revenue and Growth Rate (2014-2019)
Figure UK Rare Hematology Revenue and Growth Rate (2014-2019)
Figure France Rare Hematology Revenue and Growth Rate (2014-2019)
Figure Russia Rare Hematology Revenue and Growth Rate (2014-2019)
Figure Italy Rare Hematology Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Rare Hematology Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Rare Hematology Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Rare Hematology Revenue Market Share by Countries in 2018
Figure China Rare Hematology Revenue and Growth Rate (2014-2019)
Figure Japan Rare Hematology Revenue and Growth Rate (2014-2019)
Figure Korea Rare Hematology Revenue and Growth Rate (2014-2019)
Figure India Rare Hematology Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Rare Hematology Revenue and Growth Rate (2014-2019)
Table South America Rare Hematology Revenue by Countries (2014-2019)
Table South America Rare Hematology Revenue Market Share by Countries (2014-2019)
Figure South America Rare Hematology Revenue Market Share by Countries (2014-2019)
Figure South America Rare Hematology Revenue Market Share by Countries in 2018
Figure Brazil Rare Hematology Revenue and Growth Rate (2014-2019)
Figure Argentina Rare Hematology Revenue and Growth Rate (2014-2019)
Figure Colombia Rare Hematology Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Rare Hematology Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Rare Hematology Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Rare Hematology Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Rare Hematology Revenue Market Share by Countries in 2018
Figure Saudi Arabia Rare Hematology Revenue and Growth Rate (2014-2019)
Figure UAE Rare Hematology Revenue and Growth Rate (2014-2019)
Figure Egypt Rare Hematology Revenue and Growth Rate (2014-2019)
Figure Nigeria Rare Hematology Revenue and Growth Rate (2014-2019)
Figure South Africa Rare Hematology Revenue and Growth Rate (2014-2019)
Table Global Rare Hematology Revenue (Million USD) by Type (2014-2019)
Table Global Rare Hematology Revenue Share by Type (2014-2019)
Figure Global Rare Hematology Revenue Share by Type (2014-2019)
Figure Global Rare Hematology Revenue Share by Type in 2019
Table Global Rare Hematology Revenue Forecast by Type (2019-2024)
Figure Global Rare Hematology Market Share Forecast by Type (2019-2024)
Figure Global Recombinant Factors Revenue Growth Rate (2014-2019)
Figure Global Plasma Derived Factors Revenue Growth Rate (2014-2019)
Table Global Rare Hematology Revenue by Application (2014-2019)
Table Global Rare Hematology Revenue Share by Application (2014-2019)
Figure Global Rare Hematology Revenue Share by Application (2014-2019)
Figure Global Rare Hematology Revenue Share by Application in 2019
Table Global Rare Hematology Revenue Forecast by Application (2019-2024)
Figure Global Rare Hematology Market Share Forecast by Application (2019-2024)
Figure Global Pediatric Revenue Growth Rate (2014-2019)
Figure Global Adult Revenue Growth Rate (2014-2019)
Figure Global Rare Hematology Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Rare Hematology Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Rare Hematology Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Rare Hematology Revenue Market Forecast (2019-2024)
Figure Europe Rare Hematology Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Rare Hematology Revenue Market Forecast (2019-2024)
Figure South America Rare Hematology Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Rare Hematology Revenue Market Forecast (2019-2024)
レア血液学的治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Growing prevalence of various blood diseases such as anemia, myeloma, leukemia and sickle cell anemia has led the hematologists to focus on various detection processes. As demand for comparatively conducting comparatively short diagnosis process is becoming the need of the hour, hematologists are lo…- 世界の血液消耗品市場：市場規模・現状・予測 The hematology consumables refer to calibrators, controls and regents.In 2018, the global Hematology Consumables market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Hematology Consumables…
- 世界の血液学的コントロール市場2019 The global Hematology Controls market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Hematology Controls market status and forecast, categorizes the global Hematology Controls market size (value &…
- 世界の血液学療法市場：市場規模・現状・予測 Hematology is a branch of medicine concerned with the study of blood, blood disease and the organs involved in forming blood.In 2018, the global Hematology Therapies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. Thi…
- 血液分析装置市場：世界及び中国市場分析・予測（～2024年） Hematology Analyzers Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Hematology Analyzers industry with a focus on the Chinese market. The report provides key statistics on the market status of the Hematology Analyzers manufac…